Drug Trial Radar · NCT06401330
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,656
Planned (sponsor's estimate)
Start
Apr 15, 2025
Primary completion
Feb 13, 2031
Study completion Feb 13, 2031
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- First posted
- May 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype. Previous large clinical trials have established treatment plans that are likely to cure most children with FHWT, however some children still have their cancer come back (called relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk" refers to the chance of the cancer coming back after treatment. Using results of tumor histology tests, biology tests, and response to therapy may be able to improve treatment for children with FHWT.
Conditions
- Stage I Mixed Cell Type Kidney Wilms Tumor
- Stage II Mixed Cell Type Kidney Wilms Tumor
- Stage III Mixed Cell Type Kidney Wilms Tumor
- Stage IV Mixed Cell Type Kidney Wilms Tumor
Interventions
Bone ScanProcedure
Undergo bone scan for patients with metastatic sites outside the chest/abdomen/pelvis documented during therapy
CarboplatinDrug
Given IV
Computed TomographyProcedure
Undergo CT
CyclophosphamideDrug
Given IV
DactinomycinBiological
Given IV
DoxorubicinDrug
Given IV
EtoposideDrug
Given IV
IrinotecanDrug
Given IV
Magnetic Resonance ImagingProcedure
Undergo MRI
NephrectomyProcedure
Undergo nephrectomy
Patient ObservationOther
Undergo observation after nephrectomy
Positron Emission TomographyProcedure
Undergo PET for patients with metastatic sites outside the chest/abdomen/pelvis documented during therapy
Ultrasound ImagingProcedure
Undergo ultrasound
VincristineDrug
Given IV
X-Ray ImagingProcedure
Undergo X-ray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival (EFS)Time frame: Up to 4 years from study entry
Locations
169 sites in 4 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama · Recruiting
USA Health Strada Patient Care Center
Mobile, Alabama · Recruiting
Providence Alaska Medical Center
Anchorage, Alaska · Recruiting
Banner Children's at Desert
Mesa, Arizona · Recruiting
Phoenix Childrens Hospital
Phoenix, Arizona · Recruiting
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Kaiser Permanente Downey Medical Center
Downey, California · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
Loma Linda University Medical Center
Loma Linda, California · Recruiting
Miller Children's and Women's Hospital Long Beach
Long Beach, California · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
Valley Children's Hospital
Madera, California · Recruiting
UCSF Benioff Children's Hospital Oakland
Oakland, California · Recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Children's Hospital of Orange County
Orange, California · Recruiting
Lucile Packard Children's Hospital Stanford University
Palo Alto, California · Recruiting
University of California Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
Rady Children's Hospital - San Diego
San Diego, California · Recruiting
UCSF Medical Center-Mission Bay
San Francisco, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Denver, Colorado · Recruiting
Connecticut Children's Medical Center
Hartford, Connecticut · Recruiting
Yale University
New Haven, Connecticut · Recruiting
Alfred I duPont Hospital for Children
Wilmington, Delaware · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Broward Health Medical Center
Fort Lauderdale, Florida · Recruiting
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida · Recruiting
UF Health Cancer Institute - Gainesville
Gainesville, Florida · Recruiting
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida · Recruiting
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida · Recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida · Recruiting
Nicklaus Children's Hospital
Miami, Florida · Recruiting
Arnold Palmer Hospital for Children
Orlando, Florida · Recruiting
Nemours Children's Hospital
Orlando, Florida · Recruiting
Nemours Children's Clinic - Pensacola
Pensacola, Florida · Recruiting
Johns Hopkins All Children's Hospital
St. Petersburg, Florida · Recruiting
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida · Recruiting
Saint Mary's Medical Center
West Palm Beach, Florida · Recruiting
Showing 40 of 169 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.